Skip to main content
Premium Trial:

Request an Annual Quote

Promega Provides ATCC Access to Labeling Technologies

NEW YORK (GenomeWeb News) – ATCC on Thursday announced a non-exclusive licensing deal to develop, receive, and distribute biological materials containing Promega's labeling technologies.

The materials from ATCC will contain Promega's NanoLuc, GloSensor, and HaloTag technologies, and the deal covers new and existing products.

"Through this trio of new technologies, ATCC is now better able to [access], develop, and distribute novel products, and deliver new services, which will drive biological research," Brian Pollok, president of ATCC, said in a statement.

NanoLuc is an ATP-independent luciferase that uses a novel coelenterazine analog to produce high intensity, glow-type luminescence. GloSensor uses bioluminescence for the intracellular detection of signal transduction in living cells, and HaloTag, based on the formation of a covalent bond between a protein tag and synthetic ligands, enables the understanding of protein functions in a cellular and biochemical environment, ATCC said.

Financial and other terms of the deal were not disclosed.

Last year, the companies collaborated on cell banking and the bioproduction of cells for the creation of bioluminescence-based drug discovery assays for biologics.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.